Print

Universal Influenza Immunization Program (UIIP)

The following provides information about the Ontario Ministry of Health and Long-Term Care's (the ministry's) Universal Influenza Immunization Program (UIIP) for the 2018/2019 influenza season. The UIIP offers influenza vaccine free of charge each year to all individuals six months of age and older who live, work or go to school in Ontario.

As in previous years, immunization of groups at high risk and those capable of transmitting influenza to them should be immunized as soon as influenza vaccine is available.

Influenza immunization for the general population can begin on or after the UIIP launch date, October 22, 2018.

Groups for which immunization should occur as soon as influenza vaccine is available include:

2018/2019 UIIP Influenza Vaccine Products

Table 1: Publicly funded influenza vaccines available through the 2018/2019 UIIP
Vaccine products Quadrivalent Inactivated Vaccines (QIVs) Quadrivalent - Live Attenuated Influenza Vaccine (Q-LAIV) High-Dose Trivalent Inactivated Vaccine (high-dose TIV)
FluLaval® Tetra Quadrivalent Fluzone® Quadrivalent FluMist® Quadrivalent Fluzone® High-Dose
Dosage 0.5mL 0.5mL 0.2 mL
(0.1mL in each nostril)
0.5mL
Format Multi-dose vial Multi-dose Vial (MDV) Prefilled syringe (PFS) Prefilled single use sprayer Prefilled syringe
Administration Route Intramuscular Injection Intramuscular Injection Intranasal spray Intramuscular Injection
Age indications as per product monograph
(UIIP eligibility see Table 2)
6 months 6 months 2 to 59 years 65 years
Most common allergens Egg Protein*
Thimerosal
MDV Egg Protein*
Thimerosal
PFS Egg Protein*
Arginine
Egg Protein*
Gelatin
Gentamicin
Egg Protein*
Post-Puncture Shelf Life 28 days
MDV 28 days
PFS N/A
N/A N/A

Package Dimensions
in cm
(l x w x h)

3 x 3 x 6
MDV 3.6 x 2.9 x 6
PFS 10.4 x 8.9 x 3.8
10.6 x 17.6 x 2.9 10.4 x 8.9 x 2.3

* The National Advisory Committee on Immunization (NACI) indicates that egg-allergic individuals may be vaccinated against influenza using the full dose of any appropriate product, including QIV, Q-LAIV and high-dose TIV

Important Notes:

UIIP Vaccines for Specific Age Groups:

Table 2: Publicly funded influenza vaccine eligibility for specific age groups
Age Group
QIV
Q-LAIV
high-dose TIV
6 to 23 months
2 to 17 years
18 to 64 years
65 years

Note: NACI has not identified any preference between Q-LAIV and QIV products nor high-dose TIV and QIV products.

Influenza Vaccine Ordering

How to Order

Product Availability

Timing of Product Availability

All required fields of the Influenza Vaccine Order Form for the UIIP must be completed to ensure orders are filled.

Vaccine Wastage and Cold Chain Requirements:

Program Specific Information for the Various UIIP Participants

Additional Resources and Information

Questions

For More Information

Please e-mail uiip.moh@ontario.ca or call Service Ontario, INFOline at 1 877-844-1944